| Literature DB >> 27188200 |
Seesai Yeesoonsang1, Surichai Bilheem1, Edward McNeil1, Sophon Iamsirithaworn2, Chuleeporn Jiraphongsa3, Hutcha Sriplung1.
Abstract
PURPOSE: Histological specimens are not required for diagnosis of liver and bile duct (LBD) cancer, resulting in a high percentage of unknown histologies. We compared estimates of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) incidences by imputing these unknown histologies.Entities:
Keywords: Cholangiocarcinoma; Estimation techniques; Hepatocellular carcinoma; Incidence; Thailand
Mesh:
Year: 2016 PMID: 27188200 PMCID: PMC5266391 DOI: 10.4143/crt.2016.045
Source DB: PubMed Journal: Cancer Res Treat ISSN: 1598-2998 Impact factor: 4.679
Fig. 1.Percentage of histologic tpyes of liver and bile duct cancer in both sexes by calendar year. The percentage of cases with unknown histologic type (orange line) increased from around 40% in 1999 to 70% in 2005 and then plateaued. The percentage of hepatocellular carcinoma (blue line) decreased rapidly in 2000 and then showed a steady decline.
Fig. 2.The percentage of cases with morphologic verification (% MV; basis of diagnosis code, 5-8) and the percentage of cases with imaging verification (% IV; basis of diagnosis code, 2-8) by calendar year. The pathological diagnosis declined from 1998 to 2005 and then plateaued while the use of imaging in diagnosis of liver and bile duct cancer increased from 1989 through around 2000 and then plateaued at around 90%.
Distribution of liver and bile duct cancer cases by histological type and sex in Songkhla, Thailand, 1989-2013
| Histological type | Total (n=2,387) | Male (n=1,776) | Female (n=611) | p-value |
|---|---|---|---|---|
| HCC | 409 (17.1) | 329 (18.5) | 80 (13.1) | 0.003 |
| CCA | 358 (15.0) | 206 (11.6) | 152 (24.9) | < 0.001 |
| Other | 165 (6.9) | 89 (5.0) | 76 (12.4) | < 0.001 |
| Unknown | 1,455 (61.0) | 1,152 (64.9) | 303 (49.6) | < 0.001 |
Values are presented as number (%). HCC, hepatocellular carcinoma; CCA, cholangiocarcinoma.
Distribution of histologic type of LBD cancer cases by sex after multiple imputation in Songkhla, Thailand, 1989-2013
| Histologic type | Model 2: LBD cancers with unknown histology only | Model 3: LBD cancers with unknown histology+C76.2 and C80.9 | ||
|---|---|---|---|---|
| Male (n=1,152) | Female (n=303) | Male (n=1,323) | Female (n=421) | |
| 95% PI (n) | 586 (552-620) | 74 (64-84) | 675 (639-711) | 104 (89-119) |
| 95% PI (%) | 50.9 (47.9-53.8) | 24.4 (21-27.9) | 51 (48.3-53.8) | 24.7 (21.3-28.2) |
| 95% PI (n) | 394 (362-426) | 152 (140-164) | 451 (363-423) | 211 (140-164) |
| 95% PI (%) | 34.2 (31.4-37) | 50.2 (46.2-54.2) | 34.1 (31.5-36.7) | 50.1 (46.1-54.1) |
| 95% PI (n) | 172 (148-196) | 77 (66-88) | 197 (149-194) | 106 (66-87) |
| 95% PI (%) | 14.9 (12.8-17) | 25.4 (21.9-28.9) | 14.9 (12.9-16.8) | 25.2 (21.7-28.7) |
LBD, liver and bile duct; C76.2, unknown primary in the abdomen; C80.9, unknown primary site, not otherwise specified; HCC, hepatocellular carcinoma; PI, probability interval; CCA, cholangiocarcinoma; OSCA, other specified histology cancers.
Fig. 3.Age standardized incidence rates (ASR) of liver and bile duct (LBD) cancers in Songkhla from 1989 to 2013 for the two major histologic categories; hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), stratified by sex. Model 1, complete-case analysis; model 2, multiple imputation (MI) with LBD cancers with unknown histology only; model 3, MI of LBD cancers with unknown histology combined with cancer of unknown primary in the abdomen (C76.2) and unknown primary site, not otherwise specified (C80.9).